EMT, the process by which epithelial cells acquire mesenchymal features, is associated in cancer with tumor invasion, initiation, metastasis, and resistance to therapy (29), notably with EGFR and ALK inhibitors in EGFR-mutation-positive and ALK-fusion-positive NSCLC models (30, 31). The gene discussed is ALK; the disease is neoplasm.